Skip to content
OpenCapital
Get started

Collegium Pharmaceutical, Inc. COLL Intangibles (Net)

Intangibles (Net) at other companies

Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$121.97M-17.2%
Avanos Medical logo
Avanos MedicalAVNS
$114.7M+7.0%
Pacira BioSciences, Inc. logo
Pacira BioSciences, Inc.PCRX
$319.49M-15.2%
Supernus Pharmaceuticals logo
Supernus PharmaceuticalsSUPN
$549.71M+9.5%
Rhythm Pharmaceuticals, Inc. logo
Rhythm Pharmaceuticals, Inc.RYTM
$5.11M-14.3%
Organon logo
OrganonOGN
$1.1B-22.4%

Segments

By product

See full
Jornay PM$502.97M-14.3%
Belbuca$56.54M-57.1%
Symproic and other$42.5M-14.6%
Symproic$40.68M-15.2%

Other financials

Income statement

See full
Revenue$193.5M+8.9%
Gross profit$117.2M+20.5%
Operating income$30.9M+42.5%
Net income$14.5M+500%
EPS (diluted)$0.40+471%

Balance sheet

See full
Cash & equivalents$289.6M+147%
Total debt$5.2M-19.5%
Total equity$312.4M+33.3%
Total assets$1.7B+1.3%

Cash flow

See full
Operating cash flow$57.1M+3.1%
CapEx$270.0K-66.2%
Free cash flow$56.8M+4.1%

Valuation

See full
Market cap$1.15B+20.4%
Enterprise value$869.67M+2.5%
P/E15.4×-6.4×
P/S1.5×0.0×

Profitability

See full
Gross margin60.7%+3.0pp
Operating margin23.7%+2.3pp
Net margin9.4%+2.8pp
FCF margin41.4%+10.4pp

Returns & leverage

See full
Return on equity27.4%+8.2pp
Debt / equity0×0.0×
Current ratio1.7×+0.6×

Where this comes from

Reported directly by Collegium Pharmaceutical, Inc. in its filing.

Tagged under the XBRL concept us-gaap:FiniteLivedIntangibleAssetsNet.

The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Collegium Pharmaceutical, Inc.'s intangibles (net).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Collegium Pharmaceutical, Inc.'s intangibles (net)?
Collegium Pharmaceutical, Inc. (COLL) reported intangibles (net) of $614.04M in Q1 2026.
How has Collegium Pharmaceutical, Inc.'s intangibles (net) changed year-over-year?
Collegium Pharmaceutical, Inc.'s intangibles (net) decreased by 26.5% year-over-year, from $835.93M to $614.04M.
What is the long-term trend for Collegium Pharmaceutical, Inc.'s intangibles (net)?
Over 4 years (2021 to 2025), Collegium Pharmaceutical, Inc.'s intangibles (net) has grown at a 25.6% compound annual growth rate (CAGR), from $268.72M to $669.51M.
What does intangibles (net) mean?
Identifiable intangible assets (patents, trademarks, customer relationships, technology) net of accumulated amortization — excluding goodwill.